Replies to post #33331 on Intellipharmaceutics International Inc. (IPCI)

[TRENDmendous]

Yeah I was thinking about that too. However, with the way things/luck have been going for IPCI... You know damn well, the company buying Mallinckrodt's generic division will have ALL 3! LMAO

[tilator]

I really don't think you terminate this agreement unless you have something else in place for all 3 drugs.

At least one of them should have a new partner available and expected sales to be at least tens of millions yearly.

[doogdilinger]

The problem is that MNK's failing at even finding a buyer for their generics division a full year after they've been trying.

Hell MNK would be better off at this point re-igniting their generics division and then sitting back hoping some potential buyer comes to them.

As it stands right now MNK continues to make their generics division worth less and less with each and every passing quarter...and instead of creating any interest in their generics division they've basically succeeded in all but killing any potential interest in it.

https://seekingalpha.com/article/4141050-mallinckrodt-generics-sale-trouble

Legal risks related to Specialty Generics (which includes opioids) may have scared buyers away.

https://seekingalpha.com/article/4151740-mallinckrodt-acthar-deteriorating-credit-metrics-concerning